Molecular mechanism for the inhibitory action of interferon on hematopoiesis.
Spleen cell suspensions obtained from adult mice were separated by Ficoll/Hypaque and Percoll density gradient centrifugation. The enriched erythroblast populations were maintained in liquid culture medium for 8 hours with 10,000 units of murine interferon (IFN) alpha and beta. Exposure of these cell cultures to murine IFN alpha and beta resulted in a 48% to 70% increase in 2-5adenylate synthetase (2-5AS) activity. In parallel studies, adult mice were injected daily for 1 or 2 weeks with recombinant human IFN alpha A/D (rHuIFN alpha A/D) at a dose of 10(6) or 10(7) units/kg body weight. This treatment did not significantly affect body weight but did produce a mean 70% increase in spleen wet weight and a mean 46% increase in number of nucleated cells per spleen. This increase in number of splenic hematopoietic cells did not result in a corresponding increase in number of circulating cells. In fact, during this 1 to 2 week period the hematocrit dropped from 45% to 38% in mice injected with high dose rHuIFN alpha A/D. From these findings we propose that IFN induces an early 2-5AS activity in erythroblasts and megakaryocytes. This 2-5AS activity, which is known to inhibit protein synthesis in other cell systems, is thought to be responsible for the block or prolongation in blood cell maturation observed in the present studies.
Orlic
D
D
Department of Cell Biology and Anatomy, New York Medical College, Valhalla 10595.
Gill
R
R
Feldschuh
R
R
Quaini
F
F
Malice
A
A
Sandoval
C
C
D000818:Animals; D001792:Blood Platelets; D002478:Cells, Cultured; D002499:Centrifugation, Density Gradient; D004900:Erythroblasts; D004920:Erythropoiesis; D005260:Female; D006400:Hematocrit; D006410:Hematopoiesis; D007370:Interferon Type I / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D011994:Recombinant Proteins; D013154:Spleen / Q000166:cytology
D007370:Interferon Type I; D011994:Recombinant Proteins